Skip to main content
Clinical Trials/NCT02244619
NCT02244619
Completed
Phase 4

Randomized, Double-Blind, Study Comparing Oral Acetaminophen Plus Intravenous (IV) Placebo to Oral Placebo Plus IV Acetaminophen Given Perioperatively for Controlling Pain in the 24hr Post-op Period After Total Hip or Knee Joint Replacement

Kettering Health Network1 site in 1 country515 target enrollmentSeptember 2014

Overview

Phase
Phase 4
Intervention
Oral acetaminophen
Conditions
Post-op Pain
Sponsor
Kettering Health Network
Enrollment
515
Locations
1
Primary Endpoint
Total Post-operative Use of Opioids
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of the study is to evaluate post-op pain requirements in patients undergoing hip or knee replacement surgery who perioperatively receive either Oral acetaminophen or IV acetaminophen

Detailed Description

Subjects will be randomized to receive perioperative dosing of either: 1. Oral acetaminophen (Tylenol) 1000mg with IV Placebo (100ml Normal Saline), OR, 2. IV acetaminophen (Ofirmev) 1000mg/100ml with Oral Placebo (oral capsules). Subject pain levels and post-operative opioid use will be tracked for up to 24 hours after surgery.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
April 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age and older
  • Able to provide written consent
  • Able to read and write in English
  • Weighing over 50 kg
  • Will undergo total hip or total knee joint replacement

Exclusion Criteria

  • Non-verbal patients
  • Unable to use numeric pain scale
  • Allergic to the test article
  • Documented hepatic impairment or failure
  • Current illicit drug use
  • Requires traumatic or emergent surgery
  • Pregnant women
  • Women who are breastfeeding
  • Prisoners
  • Cognitively impaired requiring Legally Authorized Representative (LAR) or Power of Attorney (POA)

Arms & Interventions

Oral acetaminophen

Subjects receive 2 capsules each containing Tylenol 500 mg caplets. The test article administration will be initiated 60 minutes (± 15 minutes) prior to the scheduled surgery start time.

Intervention: Oral acetaminophen

IV acetaminophen

Subjects receive Ofirmev 1000 mg in 100 ml Normal Saline IV infusion. The test article will be given perioperatively at the discretion of the attending anesthesiologist.

Intervention: IV acetaminophen

Outcomes

Primary Outcomes

Total Post-operative Use of Opioids

Time Frame: During post-op period up to 24 hrs after surgery

Post-operative use of opioids, measured in morphine milligram equivalent (MME) units

Secondary Outcomes

  • Patient-rated Pain in the Post-operative Period(Standard-of-care post-op assessment intervals during post-op period up to 24 hrs after surgery)

Study Sites (1)

Loading locations...

Similar Trials